Mansano, Andre Marques; Frederico, Thiago Nouer; Valentin, Raquel Elisa B; Carmona, Maria Jose Carvalho 
; Ashmawi, Hazem Adel
Source: Pain medicine. Unidade: FM
Subjects: CARCINOMA DE CÉLULAS ESCAMOSAS, QUIMIOTERÁPICOS, INIBIDORES DE ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MANSANO, Andre Marques et al. Percutaneous radiofrequency ablation for trigeminal neuralgia management: a randomized, double-blinded, sham-controlled clinical trial. Pain medicine, v. 24, n. 3, p. 234-243, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/52813. Acesso em: 06 jul. 2024.APA
Mansano, A. M., Frederico, T. N., Valentin, R. E. B., Carmona, M. J. C., & Ashmawi, H. A. (2023). Percutaneous radiofrequency ablation for trigeminal neuralgia management: a randomized, double-blinded, sham-controlled clinical trial. Pain medicine, 24( 3), 234-243. doi:10.1093/pm/pnac132NLM
Mansano AM, Frederico TN, Valentin REB, Carmona MJC, Ashmawi HA. Percutaneous radiofrequency ablation for trigeminal neuralgia management: a randomized, double-blinded, sham-controlled clinical trial [Internet]. Pain medicine. 2023 ; 24( 3): 234-243.[citado 2024 jul. 06 ] Available from: https://observatorio.fm.usp.br/handle/OPI/52813Vancouver
Mansano AM, Frederico TN, Valentin REB, Carmona MJC, Ashmawi HA. Percutaneous radiofrequency ablation for trigeminal neuralgia management: a randomized, double-blinded, sham-controlled clinical trial [Internet]. Pain medicine. 2023 ; 24( 3): 234-243.[citado 2024 jul. 06 ] Available from: https://observatorio.fm.usp.br/handle/OPI/52813
